Compare the Effects of Transversalis Fascia Plane Block versus Intravenous Lidocaine Infusion on the Quality of Early Postoperative Recovery in Patients Undergoing Gynecologic Laparoscopic Surgery [Letter]

Effects of Transversalis Fascia Plane Block versus Intravenous Lidocaine Infusion on the Quality of Early Postoperative Recovery in Patients UndergoingGynecologic Laparoscopic Surgery published in your esteemed journal. 1 The authors elegantly examined compares the effects of transversalis fascia plane (TFP) block and intravenous lidocaine infusion on early postoperative recovery in gynecologic laparoscopic surgery, which equivalence of the two schemes in terms of postoperative recovery quality has been clarified, providing direct evidence support for the clinical decision-making of choosing between analgesia.However, several drug dosage units, outcome measure consistency, and mechanism analysis issues merit further discussion to enhance the reliability and clinical applicability of the study results.First, an error in the dosage units of sufentanil and remifentanil was identified in the study.In the anesthesia management section, the induction dose of sufentanil is defined as 0.3 μg/kg, with an additional 10 μg is administered preoperatively; 100 μg of sufentanil is incorporated into the patient-controlled intravenous analgesia (PCIA) postoperatively.Anesthesia is maintained with a continuous infusion of remifentanil at 0.1-0.2μg/kg/min.Based on the BMI and operative duration listed in Table 1, the total consumption of remifentanil and sufentanil should be expressed in μg (micrograms).This is consistent with the methodological practice by Zhong et al, who reported the consumption of these two analgesics in μg in analogous surgical studies. 2 However, a critical discrepancy exists in the original study: the unit assigned to the column "Sufentanil and remifentanil consumption" is incorrectly labeled as mg (milligrams) in Table 1.The correct unit should be μg.This unit error may mislead readers in the result, particularly clinical practitioners, regarding the actual medication dosages utilized in the study, and could potentially undermine the credibility of the intraoperative medication data presented.Second, inconsistencies exist between the quality of recovery-15 (QoR-15) score interpretations and the data presented in Table 3.In the results section, the authors claim that postoperatively, the L group achieved significantly higher scores than the T group in both the physical comfort domain and the total QoR-15 scores (P